BMS-986470 + Famotidine + PANTOPRAZOLE for anemia, sickle cell

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Jul 2024: Trial registered, NCT06481306
  2. 17 Jul 2024: Trial started, NCT06481306

The trials

NCT06481306: A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

State
Under way
Phase
Phase 1 and Phase 2
People
224 planned
Started
17 Jul 2024
Primary completion
6 Jan 2027
Arms
Cohort A Part 3
Results
None posted
  1. 1 Jul 2024: Trial registered
  2. 17 Jul 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.